Stock Research Monitor: RKDA, IPI, and MBII
LONDON, UK / ACCESSWIRE / June 26, 2018/ If you want a free Stock Review on CF sign up now at www.wallstequities.com/registration. Today, WallStEquities.com covers Arcadia Biosciences Inc. (NASDAQ: RKDA), CF Industries Holdings Inc. (NYSE: CF), Intrepid Potash Inc. (NYSE: IPI), and Marrone Bio Innovations Inc. (NASDAQ: MBII). These stocks belong to the Agricultural Chemicals industry, which is an important aspect of modern agriculture worldwide. Also known as the agrichemical industry or agrochemical industry, it encompasses the various chemical products used in the agricultural industry. All you have to do is sign up today for this free limited time offer by clicking the link below.
Davis, California headquartered Arcadia Biosciences Inc.'s shares dropped 3.94%, closing Monday's trading session at $8.04. The stock recorded a trading volume of 267,661 shares. The Company's shares are trading 20.35% below their 200-day moving average. Additionally, shares of Arcadia Biosciences, which develops and commercializes health and nutrition ingredient traits worldwide, have a Relative Strength Index (RSI) of 34.38.
On June 14th, 2018, Arcadia Biosciences announced the closing of its previously announced registered direct offering of 1,392,345 shares of the Company's common stock. The offering was priced at-the-market at a purchase price of $9.93 per share, for gross proceeds of approximately $13.83 million. Get the full research report on RKDA for free by clicking below at:
CF Industries Holdings
On Monday, shares in Deerfield, Illinois headquartered CF Industries Holdings Inc. recorded a trading volume of 2.37 million shares. The stock declined 2.89%, ending the day at $43.99. The Company's shares have advanced 6.23% in the past month, 17.78% in the previous three months, and 60.26% over the past year. The stock is trading above its 50-day and 200-day moving averages by 7.17% and 12.38%, respectively. Furthermore, shares of CF Industries, which manufactures and distributes nitrogen fertilizers and other nitrogen products worldwide, have an RSI of 55.63. CF's complimentary research coverage is a few simple steps away at:
Denver, Colorado-based Intrepid Potash Inc.'s stock finished the day 5.49% lower at $4.30 with a total trading volume of 765,843 shares. The Company's shares have advanced 14.06% in the previous three months and 86.15% over the past year. The stock is trading above its 200-day moving average by 6.42%. Additionally, shares of Intrepid Potash, which produces and sells potash and langbeinite products in the US and internationally, have an RSI of 36.79. Register for your free research report on IPI at:
Marrone Bio Innovations
Shares in Davis, California headquartered Marrone Bio Innovations Inc. ended yesterday's session 9.95% lower at $1.72. The stock recorded a trading volume of 579,833 shares. The Company's shares have advanced 0.58% in the last month and 21.13% over the past year. The stock is trading 24.76% above its 200-day moving average. Moreover, shares of the Company, which provides bio-based pest management and plant health products primarily for agricultural and water markets in the US and internationally, have an RSI of 48.98.
On June 12th, 2018, Marrone Bio Innovations announced the availability of the biological fungicide, Amplitude™, for the 2018 growing season. This product uses the same active ingredient in the recently announced EPA approval of Stargus™. Wall St. Equities' downloadable research report on MBII available at:
Wall St. Equities:
Wall St. Equities (WSE) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. WSE has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.
WSE has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third-party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email email@example.com. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by WSE. WSE is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.
WSE, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. WSE, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, WSE, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither WSE nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit
For any questions, inquiries, or comments reach out to us directly. If you're a company, we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:
Phone number: 21 32 044 483
Office Address: 1 Scotts Road #24-10, Shaw Center Singapore 228
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE: Wall St. Equities